MyFinsight
Home
Blog
About
Marketable securities
$188,158K
(0.86%↑ Y/Y)
Cash and cash
equivalents
$73,846K
(-2.15%↓ Y/Y)
Inventories
$52,251K
(5.59%↑ Y/Y)
Trade accounts
receivable, net
$49,698K
(-11.62%↓ Y/Y)
Prepaid expenses and
other current assets
$13,978K
(-7.33%↓ Y/Y)
Total current assets
$377,931K
(-1.28%↓ Y/Y)
Property and equipment,
net
$20,801K
(13.34%↑ Y/Y)
Goodwill
$16,690K
(-0.10%↓ Y/Y)
Intangible assets, net
$14,865K
(-20.08%↓ Y/Y)
Operating lease
right-of-use assets
$10,962K
(-33.11%↓ Y/Y)
Other noncurrent
assets
$5,685K
(21.40%↑ Y/Y)
Total assets
$446,934K
(-9.40%↓ Y/Y)
Total liabilities and
stockholders equity
$446,934K
(-9.40%↓ Y/Y)
Total stockholders
equity
$321,954K
(-14.73%↓ Y/Y)
Total liabilities
$124,980K
(7.96%↑ Y/Y)
Accumulated deficit
-$132,761K
(-154.41%↓ Y/Y)
Additional paid-in capital
$451,846K
(5.17%↑ Y/Y)
Total current
liabilities
$84,335K
(15.10%↑ Y/Y)
Deferred revenue,
noncurrent
$18,058K
(8.62%↑ Y/Y)
Operating lease
liability, noncurrent
$13,517K
(-4.26%↓ Y/Y)
Legal settlement
liability, noncurrent
$6,368K
(-24.88%↓ Y/Y)
Other noncurrent
liabilities
$2,456K
(-1.01%↓ Y/Y)
Long-term debt
$246K
(-68.90%↓ Y/Y)
Accumulated other
comprehensive income
$2,739K
(7307.89%↑ Y/Y)
Common stock, 0.001 par
value 1,000,000,000...
$130K
(2.36%↑ Y/Y)
Deferred revenue,
current
$29,206K
(3.83%↑ Y/Y)
Accrued expenses
$23,855K
(10.42%↑ Y/Y)
Other current
liabilities
$20,513K
(39.38%↑ Y/Y)
Trade accounts
payable
$8,408K
(22.69%↑ Y/Y)
Legal settlement
liability, current
$2,353K
(19.56%↑ Y/Y)
Back
Back
Balance Sheet
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)
source: myfinsight.com